Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients
{{output}}
Eltrombopag (ELT) is a thrombopoietin-receptor agonist that stimulates platelet (PLT) production in patients with primary immune thrombocytopenia (ITP). One potential mechanism of ELT is modulating the inflammatory response by increasing PLTs binding to leucoc... ...
